CCL2 Antikörper
-
- Target Alle CCL2 Antikörper anzeigen
- CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
-
Reaktivität
- Human, Maus, Ratte, Hund, Schwein, Rind (Kuh)
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CCL2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Human
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human CCL2
- Isotyp
- IgG
- Top Product
- Discover our top product CCL2 Primärantikörper
-
-
- Applikationshinweise
-
WB(1:100-500)
Optimal working dilution should be determined by the investigator. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C for 12 months.
- Haltbarkeit
- 12 months
-
-
The Wnt serpentine receptor Frizzled-9 regulates new bone formation in fracture healing." in: PLoS ONE, Vol. 8, Issue 12, pp. e84232, (2014) (PubMed).
: "LRRC19 expressed in the kidney induces TRAF2/6-mediated signals to prevent infection by uropathogenic bacteria." in: Nature communications, Vol. 5, pp. 4434, (2014) (PubMed).
: "The anti-inflammatory effect of kaempferol on early atherosclerosis in high cholesterol fed rabbits." in: Lipids in health and disease, Vol. 12, pp. 115, (2013) (PubMed).
: "
-
The Wnt serpentine receptor Frizzled-9 regulates new bone formation in fracture healing." in: PLoS ONE, Vol. 8, Issue 12, pp. e84232, (2014) (PubMed).
-
- Target
- CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
- Andere Bezeichnung
- MCP1/CCL2 (CCL2 Produkte)
- Synonyme
- GDCF-2 antikoerper, HC11 antikoerper, HSMCR30 antikoerper, MCAF antikoerper, MCP-1 antikoerper, MCP1 antikoerper, SCYA2 antikoerper, SMC-CF antikoerper, AI323594 antikoerper, JE antikoerper, Scya2 antikoerper, Sigje antikoerper, MCP-1A antikoerper, MCP1A antikoerper, C-C motif chemokine ligand 2 antikoerper, chemokine (C-C motif) ligand 2 antikoerper, C-C motif chemokine 2 antikoerper, CCL2 antikoerper, Ccl2 antikoerper, LOC101120093 antikoerper
- Hintergrund
-
Synonyms: C-C motif chemokine 2, HC11, Monocyte chemoattractant protein 1, Monocyte chemotactic and activating factor, MCAF, Monocyte chemotactic protein 1, MCP-1, Monocyte secretory protein JE, Small-inducible cytokine A2, CCL2, CCL-2, MCP1, SCYA2
Background: Chemotactic factor that attracts monocytes and basophils but not neutrophils or eosinophils. Augments monocyte anti-tumor activity. Has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis or atherosclerosis. May be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis.
- Molekulargewicht
- 11kDa
- Gen-ID
- 6347
- UniProt
- P13500
- Pathways
- Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, ER-Nucleus Signaling, Unfolded Protein Response, Phosphorylierungen bei SARS-CoV-2 Infektion
-